8th September 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Cipla receives approval from USFDA for cancer drug

Lenalidomide capsule, a medication used to treat various types of cancer and available in strengths of 5 mg, 10 mg, 15 mg, and 25 mg, has been approved by the US health regulator, as per drug maker Cipla.

Indian pharma to recoup from pricing pressures in the second half of FY23

Pharmaceutical companies’ fortunes have taken a turn for the worse as peak demand from the Covid-19 pandemic has faded. The margins of Indian drug companies have suffered due to high freight costs and pricing pressures in the important US generics market.

Allurion introduces its industry-leading weight management solution in India

Allurion Swallowable Capsule, the only medical weight-loss device fully approved by the Central Drugs Standard Control Organization, was introduced in India by Allurion, a company committed to ending obesity.

WHO prequalifies malaria vaccine Mosquirix from GSK

Mosquirix, GSK’s ground-breaking malaria vaccine, has received prequalification from WHO. In order to introduce the vaccine in nations with moderate to high P. falciparum malaria transmission, this is the first prequalification for a malaria vaccine.

AstraZeneca's dapagliflozin greatly reduces CV death, HF in HF, and EF in DELIVER Ph III trial

When compared to placebo, dapagliflozin from AstraZeneca significantly decreased the composite of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (EF).

All eyes on high-dose Eylea as Roche's new Vabysmo makes modest impact in blockbuster eye disease market

Roche’s Vabysmo is gaining ground in the market for treating wet AMD eye disease, but Regeneron’s mammoth Eylea is holding its own, and a new, higher dose version might further solidify Eylea’s position.

Lupin and DKSH signed an agreement to market five biosimilar candidates in Philippines

In order to commercialise five of Alvotech’s proposed biosimilars in the Philippines, Lupin Limited on Wednesday disclosed that it had signed an exclusive licence and supply agreement with DKSH.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Welcome to PharmaState Academy

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?